Hung MC - Search Results

1

Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.

Li Z, Ding Q, Li Y, Miller SA, Abbruzzese JL, Hung MC. Li Z, et al. Among authors: hung mc. Cancer Lett. 2006 May 8;236(1):58-63. doi: 10.1016/j.canlet.2005.05.001. Epub 2005 Jun 13. Cancer Lett. 2006. PMID: 15953675

2

Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.

Hung MC, Zhang X, Yan DH, Zhang HZ, He GP, Zhang TQ, Shi DR. Hung MC, et al. Cancer Lett. 1992 Jan 10;61(2):95-103. doi: 10.1016/0304-3835(92)90166-s. Cancer Lett. 1992. PMID: 1346099

3

Differential expression of the neu oncogene in mouse liver and pancreatic cell lines.

Yan DH, Marin MC, Hung MC. Yan DH, et al. Among authors: hung mc. Biochem Biophys Res Commun. 1992 Jul 15;186(1):363-70. doi: 10.1016/s0006-291x(05)80816-2. Biochem Biophys Res Commun. 1992. PMID: 1352968

4

Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.

Russell KS, Hung MC. Russell KS, et al. Among authors: hung mc. Cancer Res. 1992 Dec 1;52(23):6624-9. Cancer Res. 1992. PMID: 1358436

5

Repression of neu-induced clonogenicity by dimethylsulfoxide correlates with decreased levels of neu-encoded cell-surface p185 and changes in phosphotyrosine content of endogenous proteins.

Matin A, Hung MC. Matin A, et al. Among authors: hung mc. Cancer Lett. 1993 Jan 15;68(1):55-60. doi: 10.1016/0304-3835(93)90219-y. Cancer Lett. 1993. PMID: 7678546

6

c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.

Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC. Yu D, et al. Among authors: hung mc. Cancer Res. 1994 Jun 15;54(12):3260-6. Cancer Res. 1994. PMID: 7911396

7

Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.

Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. Yu D, et al. Among authors: hung mc. Cancer Res. 1993 Feb 15;53(4):891-8. Cancer Res. 1993. PMID: 8094034

8

Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer.

Xing X, Matin A, Yu D, Xia W, Sorgi F, Huang L, Hung MC. Xing X, et al. Among authors: hung mc. Cancer Gene Ther. 1996 May-Jun;3(3):168-74. Cancer Gene Ther. 1996. PMID: 8725881

9

Inhibition of intratracheal lung cancer development by systemic delivery of E1A.

Chang JY, Xia W, Shao R, Hung MC. Chang JY, et al. Among authors: hung mc. Oncogene. 1996 Oct 3;13(7):1405-12. Oncogene. 1996. PMID: 8875978

10

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.

Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC. Chang JY, et al. Among authors: hung mc. Oncogene. 1997 Feb 6;14(5):561-8. doi: 10.1038/sj.onc.1200861. Oncogene. 1997. PMID: 9053854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

911 results

Search Page

Filters